The adjusted ABI means and variability (standard error) by group, once controlling for differences in cystatin C as a covariate, were as follows: PAD 0.589 ± 0.13, and non-PAD 1.055 ± 0.22. This evidence concerns the gene CST3 and peripheral arterial disease.